covid
Buscar en
Revista Colombiana de Cancerología
Toda la web
Inicio Revista Colombiana de Cancerología Efectos psicológicos y sociales que genera la prueba del virus del papiloma hum...
Información de la revista
Vol. 13. Núm. 3.
Páginas 145-156 (enero 2009)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 13. Núm. 3.
Páginas 145-156 (enero 2009)
Acceso a texto completo
Efectos psicológicos y sociales que genera la prueba del virus del papiloma humano: un estudio exploratorio
An Exploratory Study of the Psychological and Social Effects of the Human Papilloma Virus Test
Visitas
25320
Carolina Wiesner Ceballos1,2,
Autor para correspondencia
cwiesner@cancer.gov.co

Correspondencia Carolina Wiesner Ceballos. Instituto Nacional de Cancerología. Av.1a No. 9-85. Tel.: (571) 3341353. Bogotá, Colombia.
, Jesús Acosta Peñaloza1, Adriana Díaz del Castillo1, Sandra Tovar Murillo1, Hernando Salcedo Fidalgo2
1 Instituto Nacional de Cancerología. Bogotá, Colombia
2 Universidad Externado de Colombia. Bogotá, Colombia
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen
Objetivo

Presentar los efectos psicológicos y sociales que tuvieron las mujeres, residentes en Bogotá, sometidas a la prueba de ADN del VPH, y la manera como los médicos comunican los riesgos a sus pacientes.

Métodos

Estudio cualitativo fenomenológico. Se realizaron 10 entrevistas semiestructuradas con mujeres que se practicaron la prueba ADN-VPH. Así mismo, se hicieron dos grupos focales: uno con médicos generales y otro con ginecólogos. Finalmente se hizo un análisis de contenido.

Resultados

El impacto psicosocial se ha clasificado en tres categorías: en la esfera emocional, en la vida sexual y de pareja y en el comportamiento. Se diseñó un modelo de los determinantes de la magnitud de los efectos. Este modelo está determinado por la forma y el contenido de la información que suministra el médico y por las características biográficas de la mujer. Los efectos encontrados fueron ansiedad, rabia, vergüenza, culpa, zozobra por la demora de los resultados, miedo al cáncer y temor a tener relaciones sexuales.

Conclusiones

La razón para practicar la prueba no debe ser promovida por el miedo al cáncer, sino por las características de la infección y la convicción sobre los beneficios de la prueba. Se debe promover una reflexión anticipada de la trayectoria de riesgos que se pueden presentar en el futuro utilizando como técnica de comunicación la toma de decisiones de manera concertada.

Palabras clave:
neoplasias del cuello uterino
impacto psicosocial
sondas ADN HPV
Abstract
Objective

To present the psychological and social effects of DNA and HPV exams among women resident in Bogotá; and, the means by which physicians communicate risks to patients. Ten, semi-structured interviews were carried out among women who underwent HPV-DNA examination. Simultaneously, two focus groups were set up: one with general practitioners and the other with gynecologists. Content analysis took place.

Methods

Qualitative study with a phenomenological perspective. Ten semi-structured interviews were conducted with women who underwent HPV testing. Two focus groups were carried out with gynecologists and medical practitioners. A content analysis was performed.

Results

Psychosocial impact has been classified into three categories: emotional; sex life and partner relationship; and, behavior. A model was designed to measure the magnitude of the effects of these determinants. This model is based upon the form and content of the information provided by physicians and by women's biographical data. The effects encountered included: anxiety, rage, shame, guilt, panic at delayed results, fear of cancer, and fear of sexual relations.

Conclusions

The reasoning to undergo examination should not be based upon fear, but rather on knowledge of infection symptoms and the conviction that the examination is beneficial. Thinking about risk trajectories should play a relevant part in the communication process based on the concept of concerted decision-making.

Keywords:
Uterine cervical neoplasma
psicosocial aspects
DNA probes, HPV
El Texto completo está disponible en PDF
Referencias
[1.]
J.G. Baseman, L.A. Koutsky.
The epidemiology of human papillomavirus infections.
J Clin Virol, 32 (2005), pp. S16-S24
[2.]
S.J. Klug, M. Hukelman, M. Blettner.
Knowledge about infection with human papillomavirus: a systematic review.
Preventive Medicine, 46 (2008), pp. 87-98
[3.]
H. Zur Hausen.
Papillomaviruses and cancer: from basic studies to clinical application.
Nat Rev Cancer, 2 (2002), pp. 342-350
[4.]
N. Muñoz, X. Castellsague, A.B. de González, L. Gissmann.
Chapter 1: HPV in the etiology of human cancer.
[5.]
E.L. Franco.
Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.
J Natl Cancer Inst Monogr, (2003), pp. 89-96
[6.]
P. Castle.
Invited commentary: Is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening?.
Am J Epidemiol, 168 (2008), pp. 138-144
[7.]
A. Webster.
Innovative Health technologies and the social: redefining health, medicine and the body.
Curr Sociol, 50 (2002), pp. 443-457
[8.]
Screening for Cervical Cancer. Agency for Healthcare research and Quality [Internet]. Rockville: Agency for Healthcare Research and Quality; 2002. [Citado: 2009 Ene 31]. Disponible en: http://www.preventiveservices.ahrq.gov.
[9.]
B. Naylor.
The century for cytopathology.
Acta Cytol, 44 (2000), pp. 709-725
[10.]
M.K. Stoler, M. Schiffman.
Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-L SIL Triage Study.
JAMA, 285 (2001), pp. 1500-1505
[11.]
G. Ronco, N. Segnan, P. Giorgi-Rossi, M. Zappa, G.P. Casadei, F. Carozzi, et al.
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
J Natl Cancer Inst, 98 (2006), pp. 765-774
[12.]
G. Ronco, P. Giorgi-Rossi, F. Carozzi, P. Dalla Palma, A. Del Mistro, L. De Marco, et al.
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial.
Lancet Oncol, 7 (2006), pp. 547-555
[13.]
L. Kotaniemi-Talonen, P. Nieminen, A. Anttila, M. Hakama.
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting.
Br J Cancer, 93 (2005), pp. 862-867
[14.]
M.H. Mayrand, E. Duarte-Franco, F. Coutlee, I. Rodrigues, S.D. Walter, S. Ratnam, et al.
Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Int J Cancer, 119 (2006), pp. 615-623
[15.]
K. McCaffery, J. Waller, J. Nazroo, J. Wardlw.
Social and psychological impact of HPV testing in cervical screening: a qualitative study.
Sex Transm Infect, 82 (2006), pp. 169-174
[16.]
M.L. Da Silva Márquez Ferreira, M.T. Gimenez.
Percepción de un grupo de mujeres acerca del hecho de ser portadoras del VPH.
Ginecol Obstet Mex, 73 (2005), pp. 531-536
[17.]
J.A. Kahn, G.B. Slap, D.I. Bernstein, L.M. Kollar, A.M. Tissot, P.A. Hillard, et al.
Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results.
J Women's Health, 14 (2005), pp. 650-659
[18.]
J. Waller, K.J. McCaffery, H.C. Kitchener, J. Nazroo, J. Wardle.
Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study.
Psychooncology, 16 (2007), pp. 196-204
[19.]
E. Maissi, T.M. Marteau, M. Hankins, S. Moss, R. Legood, A. Gray.
Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.
[20.]
J. Waller, L.A. Marlow, J. Wardle.
The association between knowledge of HPV and feelings of stigma, shame and anxiety.
Sex Transm Infect, 83 (2007), pp. 155-159
[21.]
R.G. Jepson, J. Hewison, A.G.H. Thompson, D. Weller.
How should we measure informed choice?.
The case of cancer screening. J Med Ethics, 31 (2005), pp. 192-196
[22.]
Ministerio de la Protección Social; Instituto Nacional de Cancerología.
Recomendaciones para la tamización de neoplasias del cuello uterino en mujeres sin antecedentes de patología cervical (preinvasora o invasora) en Colombia.
Guía de práctica clínica número 3, Instituto Nacional de Cancerología, (2007),
[23.]
De la Cuesta C. Estrategias cualitativas más usadas en el campo de la salud. Nure Investigación. 2006:25.
[24.]
J.A. Kahn, G.B. Slap, D.I. Bernstein, A.M. Tissot, L.M. Kollar, P.A. Hillard, et al.
Personal meaning of human papillomavirus and pap test results in adolescent and young adult women.
Health Psychology, 26 (2007), pp. 192-200
[25.]
E. Sainz, F.J. Sainz Sánchez.
La interacción comunicativa como representación: La forma del sujeto desde la Teoría de la Atribución.
REIS, 33 (1986), pp. 143-159
[26.]
R. Anhang, T. Wright, L. Smock, S. Goldi.
Women's desired information about human papillomavirus.
Cancer, 100 (2004), pp. 315-320
[27.]
D. Obregón.
Médicos, prostitución y enfermedades venéreas en Colombia (1986-1951).
Historia, Ciências, Saúde, 9 (2002), pp. S161-S186
[28.]
H.C. Kitchener, I. Fletcher, C. Roberts, P. Wheeler, M. Almonte, P. Maguire.
The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial.
Int J Gynecol Cancer, (2007 Oct 18),
Copyright © 2009. Instituto Nacional de Cancerología
Descargar PDF
Opciones de artículo